Activities of DL-α-difluoromethylarginine and polyamine analogues against Cryptosporidium parvum infection in a T-cell receptor alpha-deficient mouse model

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 4, 2007, Pages 1234-1239

  Yarlett, Nigel ^a   Waters, W Ray ^b   Harp, James A ^b   Wannemuehler, Michael J ^c   Morada, Mary ^a   Bellcastro, Josephine ^a   Upton, Steve J ^d   Marton, Laurence J ^e   Frydman, Benjamin J ^f  

^a PACE UNIVERSITY   (United States)

^b NATIONAL ANIMAL DISEASE CENTER   (United States)

^c IOWA STATE UNIVERSITY   (United States)

^d KANSAS STATE UNIVERSITY   (United States)

^e Cellgate Incorporated   (United States)

^f Omnisynthesis LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DIFLUOROMETHYLARGININE; ANTIPROTOZOAL AGENT; CGC 11047; CGC 11144; CGC 11157; CGC 11158; PAROMOMYCIN; POLYAMINE DERIVATIVE; SPERMIDINE DERIVATIVE; SPERMINE DERIVATIVE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DRUG ACTIVITY; EXPERIMENTAL MODEL; FEMALE; INTESTINE CELL; MALE; MOUSE; NONHUMAN; OOCYST; PRIORITY JOURNAL; TOXICITY TESTING; TREATMENT DURATION;

ANIMALS; ANTIPROTOZOAL AGENTS; ARGININE; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; GENES, T-CELL RECEPTOR ALPHA; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; POLYAMINES;

EID: 34247108528     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01040-06     Document Type: Article

References (36)

1. Bacchi, C. J., and N. Yarlett. 2002. Polyamine metabolism as a chemotherapeutic target in protozoan parasites. Mini Rev. Med. Chem. 2:553-563.
2. 1-acetyltransferase-the turning point in polyamine metabolism. FASEB J. 7:653-661.
3. Crawford, F. G., and S. H. Vermund. 1988. Human cryptosporidiosis. Crit. Rev. Microbiol. 16:113-159.
4. Fayer, R., C. A. Speer, and J. P. Dubey. 1997. The general biology of Cryptosporidium, p. 1-41. In R. Fayer (ed.), Cryptosporidium and cryptosporidiosis. CRC Press, Boca Raton, FL.
5. Franzen, C., and A. Muller. 1999. Cryptosporidia and microsporidia-waterborne diseases in the immunocompromised host. Diagn. Microbiol. Infect. Dis. 34:245-262.
6. Garber, L. P., H. S. Salman, H. S. Hurd, T. Keefe, and J. L. Schlater. 1994. Potential risk factors for Cryptosporidium infection in dairy calves. J. Am. Vet. Med. Assoc. 205:86-91.
7. 2+ channel activity in guinea pig intestinal smooth muscle. Pflugers Arch. 438:445-451.
8. Greco, S., L. Hugueny, P. George, P. Perrin, P. Louisot, and M. C. Biol. 2000. Influence of spermine on intestinal maturation of the glycoprotein glycosylation process in neonatal rats. Biochem. J. 345:69-75.
9. Harp, J. A., P. Jardon, E. R. Atwill, M. Zylstra, S. Checel, J. P. Goff, and C. DeSimone. 1996. Field testing and prophylactic measures against Cryptosporidium parvum infection in calves in a California dairy herd. Am. J. Vet. Res. 57:1586-1588.
10. Keithly, J. S., G. Zhu, S. J. Upton, K. M. Woods, M. P. Martinez, and N. Yarlett. 1997. Polyamine biosynthesis in Cryptosporidium parvum and its implications for chemotherapy. Mol. Biochem. Parasitol. 88:35-42.
11. Li, G., S. Regunathan, C. J. Barrow, J. Eshraghi, R. Cooper, and D. J. Reis. 1994. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263:966-969.
12. 1- acetyltransferase activity by spermine analogues and their relationship to polyamine depletion and growth inhibition in L1210 cells. Cancer Res. 49:6226-6231.
13. Majewska, A. C., P. Sulima, A. Werner, G. Baralkiewicz, J. Juszczyk, and N. J. Pieniazek. 1999. Cryptosporidosis in HIV-positive patients. Wiad. Parazytol. 45:125-128.
14. Mathews, H. R. 1993. Polyamines, chromatin structure and transcription. BioEssays 15:561-567.
15. Osborne, D. L., and E. R. Seidel. 1990. Gastrointestinal luminal polyamines: cellular accumulation and enterohepatic circulation. Am. J. Physiol. 258: G576-G584.
16. Raasch, W., S. Regunathan, G. Li, and D. G. Reis. 1995. Agmatine, the bacterial amine, is widely distributed in mammalian tissues. Life Sci. 56:2319-2330.
17. 12N-bisethyl-spermine: synthesis and growth inhibitory effects on human tumor cell lines. J. Med. Chem. 41:4723-4732.
18. Reddy, V. K., A. Sarkar, A. Valasinas, L. J. Marton, H. S. Basu, and B. J. Frydman. 2001. cis-Unsaturated analogues of 3,8,13,18,23- pentaazapentacosane (BE-4-4-4-4): synthesis and growth inhibitory effects on human prostate cancer cell lines. J. Med. Chem. 44:404-417.
19. Regunathan, S., and D. J. Reis. 2000. Characterization of arginine decarboxylase in rat brain and liver: distinction from ornithine decarboxylase. J. Neurochem. 74:2201-2208.
20. Rose, J. B., J. T. Lisle, and M. LeChevallier. 1997. Waterborne cryptosporidiosis: incidence, outbreaks and treatment strategies, p. 93-109. In R. Fayer (ed.), Cryptosporidium and cryptosporidiosis. CRC Press, Boca Raton, FL.
21. Schuber, F. 1989. Influence of polyamine on membrane function. Biochem. J. 260:1-10.
22. Seely, J. E., and A. E. Pegg. 1983. Ornithine decarboxylase (mouse kidney). Methods Enzymol. 94:158-161.
23. 3H]arginine metabolism in tobacco and mammalian cells. Inhibition of ornithine decarboxylase activity after arginase mediated hydrolysis of DL-alpha-difluoromethylarginine to DL-alpha-difluoromethylornithine. Biochem. J. 255:197-202.
24. Tadolini, B. 1988. Polyamine inhibition of lipid peroxidation. Biochem. J. 249:33-36.
25. Tzipori, S., and H. Ward. 2002. Cryptosporidosis: biology, pathogenesis and disease. Microbes Infect. 4:1047-1058.
26. Upton, S. J., M. Tilley, M. V. Nesterenko, and D. B. Brillhart. 1994. A simple and reliable method for producing in vitro infections of Cryptosporidium parvum (apicomplexa). FEMS Microbiol. Lett. 118:45-50.
27. 14N-bisethyl-homospermine (BE-4-4-4): synthesis and growth inhibitory effects on human prostate cancer cells. J. Med. Chem. 44:390-403.
28. Vargiu, C., C. Cabella, S. Belliardo, C. Cravancola, M. A. Grillo, and S. Colombatto. 1999. Agmatine modulates polyamine content in hepatocytes by inducing spermidine/spermine acetyltransferase. Eur. J. Biochem. 259:933-938.
29. Vujcics, S., P. Liang, P. Diegelman, D. L. Kramer, and C. W. Porter. 2003. Genomic identification and biochemical characterization of the mammalian polyamine oxidase involved in polyamine back-conversion. Biochem. J. 370:19-28.
30. Wallace, H. M., A. V. Fraser, and A. Hughes. 2003. A perspective of polyamine metabolism. Biochem. J. 376:1-14.
31. Wang, Y., T. Murray-Stewart, W. Devereux, A. Hacker, B. J. Frydman, P. Woster, and R. A. Casero, Jr. 2003. Properties of purified recombinant human polyamine oxidase, PAOh1/SMO. Biochem. Biophys. Res. Commun. 304:605-611.
32. Waters, W. R., and J. A. Harp. 1996. Cryptosporidium parvum infection in T-cell receptor (TCR)-α- and TCR-δ-deficient mice. Infect. Immun. 64:1854-1857.
33. Waters, W. R., T. A. Reinhardt, and J. A. Harp. 1997. Oral administration of putrescine inhibits Cryptosporidium parvum infection of neonatal C57BL-6 mice and is independent of nitric oxide synthesis. J. Parasitol. 83:746-750.
34. 12N]Bis(ethyl)-cis-6,7-dehydrospermine: a new drug for the treatment and prevention of Cryptosporidium parvum infection of mice deficient in T-cell receptor alpha. Antimicrob. Agents Chemother. 44:2891-2894.
35. Wright, R. K., B. A. Buehler, S. N. Schott, and O. Rennert. 1978. Spermine and spermidine, modulators of the cell surface enzyme adenylate cyclase. Pediatr. Res. 12:830-833.
36. 1-acetyltransferase exhibits different characteristics to the host enzyme. Mol. Biochem. Parasitol., in press.